8.9% Increase in Pain Medication Sales Since 2005

According to a news release by Reportlinker, the global market in pain medications logged $22 billion in sales in 2010, rising at a compound annual growth rate of 8.9 percent since 2005. The growth was dominated by five blockbuster pain drugs: OxyContin, Lyrica, Cymbalta and Lidoderm.

Advertisement

Leigh Page

Click here for the full Becker’s ASC Review report on the pain medication market.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Death by Infection: The Growing Global Crisis from Antimicrobial Resistance (AMR)

Recommended Whitepaper

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.